0001140361-13-046217.txt : 20131213
0001140361-13-046217.hdr.sgml : 20131213
20131213193722
ACCESSION NUMBER: 0001140361-13-046217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131211
FILED AS OF DATE: 20131213
DATE AS OF CHANGE: 20131213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN INC.
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: MYLAN LABORATORIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RIZZO DANIEL C JR
CENTRAL INDEX KEY: 0001184392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09114
FILM NUMBER: 131277476
MAIL ADDRESS:
STREET 1: GARDNER DENVER, INC.
STREET 2: 1800 GARDNER EXPRESSWAY
CITY: QUINCY
STATE: IL
ZIP: 62305
4
1
doc1.xml
FORM 4
X0306
4
2013-12-11
0
0000069499
MYLAN INC.
MYL
0001184392
RIZZO DANIEL C JR
1500 CORPORATE DRIVE
CANONSBURG
PA
15317
0
1
0
0
SVP, Corp Controller & CAO
Common Stock
2013-12-11
4
M
0
2895
20.87
A
64912
D
Common Stock
2013-12-11
4
S
0
2895
42.3709
D
62017
D
Common Stock
2013-12-11
4
M
0
2562
21.13
A
64579
D
Common Stock
2013-12-11
4
S
0
2562
42.3224
D
62017
D
Common Stock
2013-12-11
4
M
0
2263
22.66
A
64280
D
Common Stock
2013-12-11
4
S
0
2263
42.2665
D
62017
D
Common Stock
2013-12-11
4
M
0
2305
23.44
A
64322
D
Common Stock
2013-12-11
4
S
0
2305
42.2640
D
62017
D
Common Stock
2013-12-11
4
M
0
6954
21.13
A
68971
D
Common Stock
2013-12-12
4
M
0
42105
20.87
A
111076
D
Common Stock
2013-12-12
4
S
0
42105
42.00
D
68971
D
Common Stock
2013-12-12
4
M
0
4872
21.13
A
73843
D
Common Stock
2013-12-12
4
S
0
4872
42.00
D
68971
D
Common Stock
2013-12-12
4
M
0
9400
22.66
A
78371
D
Common Stock
2013-12-12
4
S
0
9400
42.00
D
68971
D
Common Stock
2013-12-12
4
M
0
4281
23.44
A
73252
D
Common Stock
2013-12-12
4
S
0
4281
42.00
D
68971
D
Common Stock
382
I
By 401(k) Plan
Stock Option Right to Buy
20.87
2013-12-11
4
M
0
2895
0
D
2016-05-30
Common Stock
2895
42105
D
Stock Option Right to Buy
21.13
2013-12-11
4
M
0
16758
0
D
2020-03-03
Common Stock
16758
4872
D
Stock Option Right to Buy
22.66
2013-12-11
4
M
0
2263
0
D
2021-03-02
Common Stock
2263
15231
D
Stock Option Right to Buy
23.44
2013-12-11
4
M
0
2305
0
D
2022-02-22
Common Stock
2305
17451
D
Stock Option Right to Buy
20.87
2013-12-12
4
M
0
42105
0
D
2016-05-30
Common Stock
42105
0
D
Stock Option Right to Buy
21.13
2013-12-12
4
M
0
4872
0
D
2020-03-03
Common Stock
4872
0
D
Stock Option Right to Buy
22.66
2013-12-12
4
M
0
9400
0
D
2021-03-02
Common Stock
9400
5831
D
Stock Option Right to Buy
23.44
2013-12-12
4
M
0
4281
0
D
2022-02-22
Common Stock
4281
13170
D
Represents the weighted average price of the reporting person's disposition of 2,895 shares in transactions ranging from $42.00 to $42.61.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 3, 4, and 5 to this Form 4.
Represents the weighted average price of the reporting person's disposition of 2,562 shares in transactions ranging from $42.00 to $42.61.
Represents the weighted average price of the reporting person's disposition of 2,263 shares in transactions ranging from $42.00 to $42.48.
Represents the weighted average price of the reporting person's disposition of 2,305 shares in transactions ranging from $42.00 to $42.45.
The officer has entered into an attestation stock swap whereby the option exercise costs have been covered by long shares owned which resulted in a net amount of 6,954 shares.
This option exercise and the related sale of the underlying common stock were executed pursuant to an amended 10b5-1 trading plan dated December 10, 2013.
The options vested in three equal installments on May 30, 2007, 2008, and 2009.
The options vested in three equal installments on March 3, 2011, 2012, and 2013.
Two-thirds of these options vested in equal installments on March 2, 2012 and 2013. The remainder of these options will vest on March 2, 2014.
One-third of these options vested on February 22, 2013. The remainder of these options will vest in equal installments on February 22, 2014, and 2015.
/s/ Daniel C. Rizzo, Jr.
2013-12-13